Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,267 public trials 445 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection

NCT00351403

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Medizinische Universitätsklinik Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Universitätsklinik Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany
  • Uniklinikum Erlangen Erlangen, Bavaria, Germany
View all 22 locations
View Trial Details
Completed

Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients

NCT00384904

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Garden State Infectious Disease Associates, Pa Voorhees Township, New Jersey, United States
  • Unc Center For Aids Research Chapel Hill, North Carolina, United States
  • Local Institution Philadelphia, Pennsylvania, United States
  • Local Institution London, Greater London, United Kingdom
View Trial Details
Completed

A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

NCT00135395

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Local Institution Hobson City, Alabama, United States
  • Local Institution Montgomery, Alabama, United States
  • Local Institution Phoenix, Arizona, United States
  • Local Institution Little Rock, Arkansas, United States
View all 53 locations
View Trial Details
Completed

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

NCT00120393

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Local Institution Phoenix, Arizona, United States
  • Local Institution Bakersfield, California, United States
  • Local Institution Los Angeles, California, United States
  • Local Institution San Francisco, California, United States
View all 14 locations
View Trial Details
Completed

DDI HV (ATV - Merck)

NCT00518297

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Bristol-Myers Squibb Clinical Pharmacology Unit Hamilton, New Jersey, United States
View Trial Details

Related conditions